AAAAAA

   
Results: 1-17 |
Results: 17
Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort
Authors: Lhatoo, SD Johnson, AL Goodridge, DM MacDonald, BK Sander, JWAS Shorvon, SD
Citation: Sd. Lhatoo et al., Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort, ANN NEUROL, 49(3), 2001, pp. 336-344
The treatment of epilepsy in developing countries: where do we go from here?
Authors: Scott, RA Lhatoo, SD Sander, JWAS
Citation: Ra. Scott et al., The treatment of epilepsy in developing countries: where do we go from here?, B WHO, 79(4), 2001, pp. 344-351
Very late onset Friedreich's presenting as spastic tetraparesis without ataxia or neuropathy
Authors: Lhatoo, SD Rao, DG Kane, NM Ormerod, IE
Citation: Sd. Lhatoo et al., Very late onset Friedreich's presenting as spastic tetraparesis without ataxia or neuropathy, NEUROLOGY, 56(12), 2001, pp. 1776-1777
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed upprospectively over 11-14 years
Authors: Lhatoo, SD Sander, JWAS Shorvon, SD
Citation: Sd. Lhatoo et al., The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed upprospectively over 11-14 years, J NE NE PSY, 71(5), 2001, pp. 632-637
Temporal lobe epilepsy following febrile seizures: Unusually prolonged latent periods
Authors: Lhatoo, SD Sander, JWAS Fish, D
Citation: Sd. Lhatoo et al., Temporal lobe epilepsy following febrile seizures: Unusually prolonged latent periods, EUR NEUROL, 46(3), 2001, pp. 165-166
Long-term treatment retention with topiramate - Reply
Authors: Lhatoo, SD Sander, JWAS Wong, ICK
Citation: Sd. Lhatoo et al., Long-term treatment retention with topiramate - Reply, EPILEPSIA, 42(2), 2001, pp. 290-291
A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy
Authors: Wong, ICK Mawer, GE Sander, JWAS Lhatoo, SD
Citation: Ick. Wong et al., A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy, EPILEPSIA, 42(10), 2001, pp. 1354-1358
The epidemiology of epilepsy and learning disability
Authors: Lhatoo, SD Sander, JWAS
Citation: Sd. Lhatoo et Jwas. Sander, The epidemiology of epilepsy and learning disability, EPILEPSIA, 42, 2001, pp. 6-9
Stopping drug therapy in epilepsy
Authors: Lhatoo, SD Sander, JWAS
Citation: Sd. Lhatoo et Jwas. Sander, Stopping drug therapy in epilepsy, CUR PHARM D, 6(8), 2000, pp. 861-863
Adverse reactions to new anticonvulsant drugs
Authors: Wong, ICK Lhatoo, SD
Citation: Ick. Wong et Sd. Lhatoo, Adverse reactions to new anticonvulsant drugs, DRUG SAFETY, 23(1), 2000, pp. 35-56
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
Authors: Lhatoo, SD Sander, JWAS Wong, ICK
Citation: Sd. Lhatoo et al., Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults, NEUROLOGY, 54(1), 2000, pp. 270-271
Prognostic factors affecting long-term retention of topiramate in patientswith chronic epilepsy
Authors: Lhatoo, SD Wong, ICK Sander, JWAS
Citation: Sd. Lhatoo et al., Prognostic factors affecting long-term retention of topiramate in patientswith chronic epilepsy, EPILEPSIA, 41(3), 2000, pp. 338-341
Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy
Authors: Lhatoo, SD Wong, ICK Polizzi, G Sander, JWAS
Citation: Sd. Lhatoo et al., Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy, EPILEPSIA, 41(12), 2000, pp. 1592-1596
Infantile spasms and vigabatrin - Visual field defects may be permanent
Authors: Lhatoo, SD Sander, JWAS
Citation: Sd. Lhatoo et Jwas. Sander, Infantile spasms and vigabatrin - Visual field defects may be permanent, BR MED J, 318(7175), 1999, pp. 57-57
The safety and adverse event profile of topiramate
Authors: Lhatoo, SD Walker, MC
Citation: Sd. Lhatoo et Mc. Walker, The safety and adverse event profile of topiramate, REV CONT PH, 10(3), 1999, pp. 185-191
Sudden unexpected death in epilepsy
Authors: Lhatoo, SD Langan, Y Sander, JWAS
Citation: Sd. Lhatoo et al., Sudden unexpected death in epilepsy, POSTG MED J, 75(890), 1999, pp. 706-709
Sudden unexpected death: a rare event in a large community based prospective cohort with newly diagnosed epilepsy and high remission rates
Authors: Lhatoo, SD Langan, Y MacDonald, BK Zeidan, S Sander, JWAS
Citation: Sd. Lhatoo et al., Sudden unexpected death: a rare event in a large community based prospective cohort with newly diagnosed epilepsy and high remission rates, J NE NE PSY, 66(5), 1999, pp. 692-693
Risultati: 1-17 |